Share on StockTwits

Analysts at Canaccord Genuity increased their price target on shares of Theratechnologies (NASDAQ:THER) from C$0.50 to C$0.60 in a research report issued to clients and investors on Thursday.

Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with Analyst Ratings Network's FREE daily email newsletter.